Multicentre observational study of natalizumab for the treatment of multiple sclerosis in pregnancy

Researchers from an Italian network of 29 MS treatment centres have published a study comparing maternal MS and pregnancy outcomes between those who discontinued natalizumab treatment prior to pregnancy, those who discontinued use in the first trimester, and those who continued use throughout pregnancy. More information can be found here.